Lorenza Mittempergher

Science Park
Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Immune Subtyping Identifies Patients With Hormone Receptor-Positive Early-Stage Breast Cancer Who Respond to Neoadjuvant Immunotherapy (IO): Results From Five IO Arms of the I-SPY2 Trial.

Immune Subtyping Identifies Patients With Hormone Receptor-Positive Early-Stage Breast Cancer Who Respond to Neoadjuvant Immunotherapy (IO): Results From Five IO Arms of the I-SPY2 Trial.

Journal: JCO precision oncology

Published: June 17, 2025

Prediction of Benefit From Adjuvant Pertuzumab by 80-Gene Signature in the APHINITY (BIG 4-11) Trial.

Prediction of Benefit From Adjuvant Pertuzumab by 80-Gene Signature in the APHINITY (BIG 4-11) Trial.

Journal: JCO precision oncology

Published: January 18, 2024

Characterization of the Tumor Microenvironment of De Novo Oligometastatic Breast Cancer in a Nationwide Cohort.

Characterization of the Tumor Microenvironment of De Novo Oligometastatic Breast Cancer in a Nationwide Cohort.

Journal: JCO precision oncology

Published: September 22, 2023

Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade.

Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade.

Journal: NPJ breast cancer

Published: July 28, 2023

BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancer.

BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancer.

Journal: Breast cancer research : BCR

Published: November 15, 2022

B-cells and regulatory T-cells in the microenvironment of HER2+ breast cancer are associated with decreased survival: a real-world analysis of women with HER2+ metastatic breast cancer.

B-cells and regulatory T-cells in the microenvironment of HER2+ breast cancer are associated with decreased survival: a real-world analysis of women with HER2+ metastatic breast cancer.

Journal: Breast cancer research : BCR

Published: April 07, 2022

BluePrint breast cancer molecular subtyping recognizes single and dual subtype tumors with implications for therapeutic guidance.

BluePrint breast cancer molecular subtyping recognizes single and dual subtype tumors with implications for therapeutic guidance.

Journal: Breast cancer research and treatment

Published: March 28, 2022

Treatment response and 5-year distant metastasis-free survival outcome in breast cancer patients after the use of MammaPrint and BluePrint to guide preoperative systemic treatment decisions.

Treatment response and 5-year distant metastasis-free survival outcome in breast cancer patients after the use of MammaPrint and BluePrint to guide preoperative systemic treatment decisions.

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 25, 2021

Allelic expression imbalance of PIK3CA mutations is frequent in breast cancer and prognostically significant.

Allelic expression imbalance of PIK3CA mutations is frequent in breast cancer and prognostically significant.

Journal: NPJ breast cancer

Published: June 02, 2021

MammaPrint and BluePrint comprehensively capture the cancer hallmarks in early-stage breast cancer patients.

MammaPrint and BluePrint comprehensively capture the cancer hallmarks in early-stage breast cancer patients.

Journal: Genes, chromosomes & cancer

Published: April 24, 2021

Kinome capture sequencing of high-grade serous ovarian carcinoma reveals novel mutations in the JAK3 gene.

Kinome capture sequencing of high-grade serous ovarian carcinoma reveals novel mutations in the JAK3 gene.

Journal: PloS one

Published: January 19, 2020

Investigating the concordance in molecular subtypes of primary colorectal tumors and their matched synchronous liver metastasis.

Investigating the concordance in molecular subtypes of primary colorectal tumors and their matched synchronous liver metastasis.

Journal: International journal of cancer

Published: November 23, 2019

Showing 1-12 of 25

Last Updated: 09/26/2026